Johnson & Johnson Q3 2024 Adj. EPS $2.42 Beats $2.21 Estimate, Sales $22.471B Beat $22.164B Estimate
Portfolio Pulse from Benzinga Newsdesk
Johnson & Johnson reported its Q3 2024 earnings, with an adjusted EPS of $2.42, surpassing the estimated $2.21. The company's sales also exceeded expectations, reaching $22.471 billion compared to the forecasted $22.164 billion.
October 15, 2024 | 10:21 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Johnson & Johnson's Q3 2024 earnings report shows an adjusted EPS of $2.42, beating the $2.21 estimate. Sales also exceeded expectations at $22.471 billion.
Johnson & Johnson's better-than-expected earnings and sales figures are likely to positively impact its stock price in the short term. Beating both EPS and sales estimates typically boosts investor confidence and can lead to a stock price increase.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100